Literature DB >> 17450050

ADHD symptoms in children with mild intellectual disability.

Emily Simonoff1, Andrew Pickles2, Nicky Wood2, Paul Gringras2, Oliver Chadwick2.   

Abstract

OBJECTIVES: To determine whether the nature and correlates of attention-deficit/hyperactivity disorder (ADHD) symptoms are different in subjects with mild intellectual disability (ID) compared to subjects with average ability.
METHOD: From a general population sample of 2,726 12- to 15-year-olds, a stratified subsample was selected to enrich for mild ID. A total of 192 subjects were included in the analyses. ADHD symptoms and other emotional/behavioral problems were measured with the parent and teacher Strengths and Difficulties Questionnaire and IQ with the WISC-III-UK), and social communication difficulties were assessed by a short version of the Social Communication Questionnaire and academic attainments by the Wechsler Quicktest.
RESULTS: There was a negative linear relationship between ADHD symptoms and IQ (beta = -.087, p <.001). The relationship could not be explained by inappropriate rater expectations. Neither the profiles of ADHD symptoms nor the comorbidity with emotional/behavioral problems differed according to the presence of ID. When IQ was accounted for, the group difference in attainments was nonsignificant.
CONCLUSIONS: ADHD symptoms are increased in people with ID. We found no evidence that this increase can by explained by inappropriate expectations or by confounding associations with other emotional/behavioral or cognitive problems.

Entities:  

Mesh:

Year:  2007        PMID: 17450050     DOI: 10.1097/chi.0b013e3180323330

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  20 in total

Review 1.  Polypharmacy in the treatment of subjects with intellectual disability.

Authors:  Frank Häβler; Johannes Thome; Olaf Reis
Journal:  J Neural Transm (Vienna)       Date:  2014-05-25       Impact factor: 3.575

2.  ADHD in Pediatric Epilepsy: Fact or Fiction?

Authors:  Rochelle Caplan
Journal:  Epilepsy Curr       Date:  2017 Mar-Apr       Impact factor: 7.500

3.  Factors Differentiating Childhood-Onset and Adolescent-Onset Schizophrenia:A Claims Database Study.

Authors:  Jeanette M Jerrell; Roger S McIntyre
Journal:  Prim Care Companion CNS Disord       Date:  2016-03-03

4.  Dual Diagnosis: A Problematic Construct When Applied to Persons with Intellectual Disabilities.

Authors:  John D McLennan
Journal:  Can J Psychiatry       Date:  2018-04-19       Impact factor: 4.356

5.  Marital Quality and Families of Children with Developmental Disabilities.

Authors:  Sigan L Hartley; Marsha Mailick Seltzer; Erin T Barker; Jan S Greenberg
Journal:  Int Rev Res Dev Disabil       Date:  2011

Review 6.  Attention deficits, Attention-Deficit Hyperactivity Disorder, and intellectual disabilities.

Authors:  Curtis K Deutsch; William V Dube; William J McIlvane
Journal:  Dev Disabil Res Rev       Date:  2008

7.  Early and Concurrent Features of ADHD and Sensory Over-Responsivity Symptom Clusters.

Authors:  Ayelet Ben-Sasson; Timothy W Soto; Amy E Heberle; Alice S Carter; Margaret J Briggs-Gowan
Journal:  J Atten Disord       Date:  2014-08-04       Impact factor: 3.256

8.  Efficacy of Methylphenidate in ADHD Children across the Normal and the Gifted Intellectual Spectrum.

Authors:  Natalie Grizenko; David Dong Qi Zhang; Anna Polotskaia; Ridha Joober
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2012-11

9.  Intellectual disability and mental disorders in a US population representative sample of adolescents.

Authors:  Jonathan M Platt; Katherine M Keyes; Katie A McLaughlin; Alan S Kaufman
Journal:  Psychol Med       Date:  2018-07-12       Impact factor: 7.723

10.  Personality characteristics of mothers of children with attention deficit hyperactivity disorder as assessed by the Minnesota multiphasic personality inventory.

Authors:  Soon Jeong Lee; Jung-Hwa Kwon; Yu Jin Lee
Journal:  Psychiatry Investig       Date:  2008-12-31       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.